1. Home
  2. CALC vs HSON Comparison

CALC vs HSON Comparison

Compare CALC & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • HSON
  • Stock Information
  • Founded
  • CALC 2011
  • HSON 1999
  • Country
  • CALC United States
  • HSON United States
  • Employees
  • CALC N/A
  • HSON N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • HSON Professional Services
  • Sector
  • CALC Health Care
  • HSON Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • HSON Nasdaq
  • Market Cap
  • CALC 32.4M
  • HSON 23.1M
  • IPO Year
  • CALC N/A
  • HSON N/A
  • Fundamental
  • Price
  • CALC $3.71
  • HSON $9.29
  • Analyst Decision
  • CALC Strong Buy
  • HSON
  • Analyst Count
  • CALC 2
  • HSON 0
  • Target Price
  • CALC $14.50
  • HSON N/A
  • AVG Volume (30 Days)
  • CALC 133.2K
  • HSON 9.4K
  • Earning Date
  • CALC 08-11-2025
  • HSON 08-07-2025
  • Dividend Yield
  • CALC N/A
  • HSON N/A
  • EPS Growth
  • CALC N/A
  • HSON N/A
  • EPS
  • CALC N/A
  • HSON N/A
  • Revenue
  • CALC N/A
  • HSON $138,031,000.00
  • Revenue This Year
  • CALC N/A
  • HSON $0.80
  • Revenue Next Year
  • CALC N/A
  • HSON $8.09
  • P/E Ratio
  • CALC N/A
  • HSON N/A
  • Revenue Growth
  • CALC N/A
  • HSON N/A
  • 52 Week Low
  • CALC $1.42
  • HSON $8.26
  • 52 Week High
  • CALC $5.97
  • HSON $18.48
  • Technical
  • Relative Strength Index (RSI)
  • CALC 71.54
  • HSON 67.56
  • Support Level
  • CALC $3.37
  • HSON $8.77
  • Resistance Level
  • CALC $4.26
  • HSON $9.19
  • Average True Range (ATR)
  • CALC 0.43
  • HSON 0.31
  • MACD
  • CALC 0.17
  • HSON 0.10
  • Stochastic Oscillator
  • CALC 79.32
  • HSON 75.88

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: